Analysis of human tumour necrosis factor receptor 1 dominant-negative mutants reveals a major region controlling cell surface expression

FEBS Letters

Volumn 570, Issue 1-3, 2004, Pages 138-142

  Fielding, Ceri A ^a   Siebert, Stefan ^a   Rowe, Martin ^a   Brennan, Paul ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Dominant negative receptor; Nuclear factor B; Structure function; Surface expression; Tumour necrosis factor receptor 1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN CELL; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS INHIBITION; RECEPTOR INTRINSIC ACTIVITY;

ANTIGENS, CD; CELL LINE, TUMOR; CELL MEMBRANE; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENES, DOMINANT; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUCIFERASES; LUMINESCENT PROTEINS; MUTATION; NF-KAPPA B; PLASMIDS; POINT MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 3142566343     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.06.035     Document Type: Article

References (26)

1. Fuchs P., Strehl S., Dworzak M., Himmler A., Ambros P.F. Genomics. 13:1992;219-224
2. Grell M., Wajant H., Zimmermann G., Scheurich P. Proc. Natl. Acad. Sci. USA. 95:1998;570-575
3. Thoma B., Grell M., Pfizenmaier K., Scheurich P. J. Exp. Med. 172:1990;1019-1023
4. Kalb A., Bluethmann H., Moore M.W., Lesslauer W. J. Biol. Chem. 271:1996;28097-28104
5. Baker S.J., Reddy E.P. Oncogene. 17:1998;3261-3270
6. Chen G., Goeddel D.V. Science. 296:2002;1634-1635
7. Tartaglia L.A., Ayres T.M., Wong G.H., Goeddel D.V. Cell. 74:1993;845-853
8. Hsu H., Xiong J., Goeddel D.V. Cell. 81:1995;495-504
9. Chinnaiyan A.M., et al. J. Biol. Chem. 271:1996;4961-4965
10. Hsu H., Huang J., Shu H.B., Baichwal V., Goeddel D.V. Immunity. 4:1996;387-396
11. Adam-Klages S., Adam D., Wiegmann K., Struve S., Kolanus W., Schneider-Mergener J., Kronke M. Cell. 86:1996;937-947
12. Hildt E., Oess S. J. Exp. Med. 189:1999;1707-1714
13. Rowe M., Rowe D.T., Gregory C.D., Young L.S., Farrell P.J., Rupani H., Rickinson A.B. EMBO J. 6:1987;2743-2751
14. Ben-Bassat H., et al. Int. J. Cancer. 19:1977;27-33
15. Chan F.K., Chun H.J., Zheng L., Siegel R.M., Bui K.L., Lenardo M.J. Science. 288:2000;2351-2354
16. Arenzana-Seisdedos F., Fernandez B., Dominguez I., Jacque J.M., Thomas D., Diaz-Meco M.T., Moscat J., Virelizier J.L. J. Virol. 67:1993;6596-6604
17. Mehl A.M., Floettmann J.E., Jones M., Brennan P., Rowe M. J. Biol. Chem. 276:2001;984-992
18. Cottin V., Doan J.E., Riches D.W. J. Immunol. 168:2002;4095-4102
19. Storey H., Stewart A., Vandenabeele P., Luzio J.P. Biochem. J. 366:2002;15-22
20. Gibbons D.L., Rowe M., Cope A.P., Feldmann M., Brennan F.M. Eur. J. Immunol. 24:1994;1879-1885
21. Tartaglia L.A., Goeddel D.V. J. Biol. Chem. 267:1992;4304-4307
22. Legler D.F., Micheau O., Doucey M.A., Tschopp J., Bron C. Immunity. 18:2003;655-664
23. Van Linden A.A., Cottin V., Leu C., Riches D.W. J. Biol. Chem. 275:2000;6996-7003
24. Cottin V., Van Linden A., Riches D.W. J. Biol. Chem. 274:1999;32975-32987
25. Yamazaki T., Zaal K., Hailey D., Presley J., Lippincott-Schwartz J., Samelson L.E. J. Cell. Sci. 115:2002;1791-1802
26. Jiang X., Huang F., Marusyk A., Sorkin A. Mol. Biol. Cell. 14:2003;858-870